Journal
ANNALS OF ONCOLOGY
Volume 26, Issue -, Pages V126-V132Publisher
OXFORD UNIV PRESS
DOI: 10.1093/annonc/mdv297
Keywords
-
Categories
Funding
- Novartis
- Merck Sharp Dohme (MSD)
- Bristol-Myers Squibb (BMS)
- Roche
- GlaxoSmithKline (GSK)
- Amgen
- BMS
- Celgene
- Eisai
- GSK
- MedImmune
- Me-laSciences
- Merck Serono
- MSD/Merck
- On-cosec
- Roche Pharma